As someone who focuses on the defense sector, Iâm no stranger to massive one-day stock surges. [Wealth Daily] Jason Simpkins / Jan 9, 2024 Massive One-Day Stock Gains Are Waiting As someone who focuses on the defense sector, Iâm no stranger to massive one-day stock surges. When Russia invaded Ukraine, my portfolio went bananas. When Hamas attacked Israel last October, it shot up again. And more recently, when shipping vessels came under fire from Iranian proxy groups, what do you think happened? Defense stocks surged. But hereâs the thing⦠Even I â someone whoâs been on the receiving end of these massive one-day defense stock explosions â can admit that theyâre few and far in between. The simple fact is most defense stocks are already mammoth. So while they may steadily advance thanks to rising defense budgets and get juicy tailwinds whenever chaos breaks out⦠Those big-time, one-day shots donât occur as often as I'd like. And if weâre being honest, thatâs probably for the best. However, there is one investing sector where big, one-day blasts occur as a matter of routine⦠And thatâs the biotech sector. Thatâs because when it comes to pharmaceuticals, thereâs a litany of milestones that each and every product must hit before it goes to market. Thereâs an entire gauntlet of trials and tests that needs to be run before a drug can be prescribed safely. Itâs an intense process and not every drug makes it through, but every hurdle that is cleared creates a massive profit tsunami for investors. And that happens more frequently than you might realize. Tiny Stock Has 264 Patents on Groundbreaking AI Tech A little-known AI tech is becoming critical to the operations of 94% of corporations... Itâs projected to be in nine out of every 10 cars by 2028... And is already essential to the workflow of 80% of hospitals. Which is the real reason why Bill Gates bet an enormous $20 billion on this AI niche... double what he invested in ChatGPT. Yet one tiny company already holds 264 ironclad patents on this tech. And it's lined up to hand savvy investors like you 5,300% profits. [Click here for the full story.]( In 2022, the FDA approved 37 new drugs, which means the government approved an average of three new treatments each month. Furthermore, there are nearly 880 publicly traded biotech companies currently developing a grand total of 8,000 new drugs as we speak. Each one of those 8,000 drugs has to go through all 12 steps of the FDA pipeline. And each of those 12 steps is a potential catalyst event that can send a biotech stock into the stratosphere. Do the math on that and it's 96,000 opportunities for investors to hit those single-day windfalls. Because each time one of these biotech companies clears one of these steps, it's a signal to the market â a clear indication that its drug or treatment is moving closer to becoming a money-minting machine. The next Lipitor or Ozempic. Iâm not kidding you when I tell you these stock gains are wild, either. Celgene, for example, returned over 6,200% for investors before being taken over by Bristol-Myers Squibb. Questcor Pharmaceuticals skyrocketed a total of 33,428% as its novel treatments for autoimmune disorders blazed through the FDA pipeline one after another. It was then taken over by Mallinckrodt. (Buyouts and takeovers are another great catalyst for massive one-day stock gains.) And genetic sequencing superstar Illumina (NASDAQ: ILMN) has generated an eye-popping 47,618% in gains for investors throughout its history. [Exploit Congressâ New Law for Easy Moneyâ¦]( Congressed just passed a brand-new law. Itâs an obscure provision in the Internal Revenue Code⦠Which allows in-the-know Americans to claim $7,882 every quarter â courtesy of the U.S. government. If your retirement nest egg is running on empty, then⦠[Click here to exploit this new law â 100% legal and ethically.]( Now, maybe you missed out on these gains and feel like you missed the boat⦠But if thatâs the case, fear not⦠Because more opportunities like these are coming down the pike. Like I said, they hit every single month, as a matter of fact. And all you need to do to get in on the massive stock gains being generated is follow these drugs through the pipeline. One of the most successful investors I know has even built a calendar around these occurrences. [TT Catalyst Calendar Gains]( Better still, heâs in touch with a vast network of more than 250 scientists and doctors. [Check that out here]( and youâll be cashing in in no time. Fight on, [Jason Simpkins Signature] Jason Simpkins [Wealth Daily ICYMI Header]( Oil Prices Skyrocket as ProtestorsShut Down Libyaâs Top Oil Field [oil storm] Oil prices are on the rise as protests disrupt supply from Libyaâs top oil field. Protestors have shut down the Sharara oil field, which produces 300,000 barrels of oil per day... causing oil prices to surge. But not only will crude oil prices continue to soar as geopolitical tensions and supply constrictions in the Middle East worsen... My research indicates that they wonât come back down for years. Most Americans will be blindsided as prices for fuel and everyday goods reach unprecedented heights. But for smart investors who know what to do, this is a rare opportunity. Thatâs why Iâm reaching out to you today. Iâve detailed the critical steps that you need to take to benefit from this massive spike in oil prices... And Iâm ready to give you the name and ticker symbol for my No. 1 oil stock to buy now. [Learn more about the biggest oil event in decades here.]( [youtube logo]( [Angelpub ARE site logo 100x100]@AngelInvestmentResearch From Crypto to Gold: Why 2024 Will Be the Year of Gold & Digital Assets | Angel Research Podcast Jason Williams returns to the Angel Research Podcast to discuss why 2024 will be the year of gold and digital assets (crypto). With Peak Gold becoming more apparent by the day, Jason has found the perfect $1 stock to take advantage of this opportunity. With mined gold output about to fall off a cliff, we're staring at the biggest event in over 300 years. On March 31, a tiny, under-the-radar stock will release drilling results that send the stock soaring... Discover how you can take advantage today on episode 68 of the Angel Research Podcast!  [From Crypto to Gold: Why 2024 Will Be the Year of Gold & Digital Assets | Angel Research Podcast](       [Feedback? get in touch](mailto:/newsletter@wealthdaily.com?subject=Wealth%20Daily%20feedback) [Read this email online]( [Manage Newsletters]( [Share on Twitter]( You signed up for our newsletter with the email {EMAIL}.
You can manage your subscription and get our privacy policy [here](. This email is from Angel Publishing, 3 East Read Street, Baltimore, MD 21202
© Wealth Daily.